Edward Penhoet
CIK 1198332 · last filed 2019-04-04
"Disclosed insider exposure" sums this person's most-recently-reported share counts across each company they're an insider in, multiplied by the current underlying price. It is not net worth — it misses retail holdings, private investments, real estate, index funds, and any company where the person isn't an SEC-reporting insider. For informational purposes only.
Charts
Trading activity, where the exposure sits, and each trade against the stock price.
CORT price and trades
Daily close with each Form 4 filing on this company marked: green = open-market buy, red = open-market sale, purple = grants, exercises, gifts and other non-market transactions. Marker size scales with the dollar value.
Shares held
Shares owned after each reported transaction on this company (direct holdings as reported).
Open-market buying and selling
by monthDollar value of open-market purchases (code P, up) and sales (code S, down) across all companies, by filing month. Grants, exercises and gifts are excluded.
Exposure by company
latestMost recently reported shares × current price. Faded bars (*) have had no filing in 3 years, so the person may no longer hold them. Click a bar to chart that company.
Filer Profile
SAN FRANCISCO, CA 94111
Holdings By Company
| Symbol | Role | Shares | Price | Disclosed Exposure | Lifetime OM Net | Filings | Latest Filed |
|---|---|---|---|---|---|---|---|
| SCYX | Director | — | $2.52 | — | $0 | 1 | 2015-06-05 |
| CymaBay Therapeutics, Inc. (CBAY) Delisted | Director | — | $32.48 | — | $0 | 1 | 2015-01-08 |
| CCXI | Director | 3,808,920 | $11.26 | $42.89M | $0 | 3 | 2013-05-24 |
| ZYMOGENETICS INC (ZGEN) Delisted | Director | 0 | $12.01 | $0 | $0 | 6 | 2010-10-12 |
| CORT | Director | 5,525,313 | $65.18 | $360.14M | $482.5K | 5 | 2010-04-06 |
| IDM PHARMA, INC. (IDMI) Delisted | Director | 1,829 | — | — | $0 | 4 | 2008-06-26 |
| RENOVIS INC (RNVS) Delisted | Director | 79,028 | — | — | $0 | 2 | 2007-05-16 |
Holdings By Holder
| Symbol | Holder | Shares | Share of Total | Reported |
|---|---|---|---|---|
| CCXI | By Alta Embarcadero BioPharma Partners III, LLC | 1,868,088 | 49.0% | 2012-02-15 |
| By Alta BioPharma Partners III, L.P. | 1,825,922 | 47.9% | 2012-02-15 | |
| By Alta BioPharma Partners III GmbH & Co. Beteiligungs KG | 114,910 | 3.0% | 2012-02-15 | |
| Total | 3,808,920 | |||
| CORT | Direct | 41,250 | 0.7% | 2010-04-06 |
| By Fund | 5,484,063 | 99.3% | 2010-04-06 | |
| Total | 5,525,313 | |||
| No longer reported | ||||
| By Limited Liability Company | 167,798 | — | last 2008-11-13 | |
| IDMI | Direct | 1,829 | 100.0% | 2007-05-22 |
| See footnotes | 0 | 0.0% | 2007-05-22 | |
| Total | 1,829 | |||
| RNVS | Direct | 79,028 | 100.0% | 2007-05-16 |
| See footnotes | 0 | 0.0% | 2007-05-16 | |
| Total | 79,028 | |||
Recent Filings · Page 2 of 4
33 filings| Filed | Symbol | Action | Net Shares | Net $ | Link |
|---|---|---|---|---|---|
| 2014-01-08 | — | Grant (A) | — | $0 | |
| 2013-11-01 | — | Grant (A) | — | $0 | |
| 2013-05-24 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-06-26 | CCXI | Grant (A) | — | $0 | EDGAR |
| 2012-02-15 | CCXI | Conv (C) | +1,868,088 | $0 | EDGAR |
| 2010-10-12 | ZYMOGENETICS INC (ZGEN) Delisted | U | −72,000 | -$702.0K | EDGAR |
| 2010-08-19 | ZYMOGENETICS INC (ZGEN) Delisted | Exer (M) | +72,000 | $200.0K | EDGAR |
| 2010-06-18 | ZYMOGENETICS INC (ZGEN) Delisted | Grant (A) | — | $0 | EDGAR |
| 2010-04-06 | CORT | Exer (M) | +41,250 | $72.9K | EDGAR |
| 2009-10-20 | CORT | Buy (P) | +349,651 | $482.5K | EDGAR |
10b5-1: the filer ticked the box for trades made under a Rule 10b5-1 trading plan, which sets the sales (or buys) in advance, so they say less about the insider's view at the time than a discretionary trade. The plan's adoption date is shown when the filing's footnotes give it.
Notice (144 / 144/A): Form 144 is a notice of intent to sell restricted/control stock under Rule 144, filed before the sale; 144/A is an amendment, and an amended or cancelled notice is not listed. Many notices are pre-scheduled under Rule 10b5-1 plans. A Form 4 with code S typically follows within a few days when the planned sale executes. Someone who is no longer an officer or director (or never was) files no Form 4, so for them a sale shows up only on a later notice, which lists the seller's sales from the 3 months before it. "No sale on file" means neither record shows one; a dash in Net $ means the value filed on the notice doesn't fit the stock's price (likely a typo).